Dr. Matthew K. Griswold, MD

Dr. Griswold practices at Hartford Hospital in Hartford, Connecticut, part of Hartford HealthCare.

Dr. Griswold's NPI, 1811250194, was assigned on June 21, 2012. Dr. Griswold graduated from Boston University School of Medicine in 2012. Dr. Griswold holds Connecticut license 056391.

Dr. Griswold's primary practice is Hartford Hospital, at 80 Seymour Street, Hartford, CT 06102 in Hartford County. The practice phone is (860) 545-5000.

Dr. Griswold's primary practice is Hartford Hospital in Hartford, Connecticut, part of Hartford HealthCare. The medical group on file is Hartford Hospital. Dmand AI also links Dr. Griswold to 1 more hospital, named with a free account. Dr. Griswold's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Griswold practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Griswold's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Griswold's licenses on file in 2 states: Connecticut and Massachusetts.

CMS data shows 278 Medicare services from Dr. Griswold across 4 procedure codes in 2024, for 287 Medicare patients. Medicare paid $37,300 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 287 Medicare patients who saw Dr. Griswold in 2024. The largest group is 75 to 84, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Griswold's median patient age at 57, with 51% women.

In 2024, Dr. Griswold wrote 17 Medicare Part D claims for 14 patients. 71% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $41 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Griswold for performance year 2024, reported as part of a group. Dr. Griswold accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Griswold, published from 2016 to 2022. 2017 was the busiest year, with 4. The most frequent topics are Drug Overdose, Analgesics, Opioid and Drug-Related Side Effects and Adverse Reactions. Dr. Griswold has published most often in J Med Toxicol. Dr. Griswold's most frequent co-authors are Peter R. Chai, MD, Edward W. Boyer, MD and Kavita M. Babu, MD.

CMS Open Payments shows 1 general payment to Dr. Griswold from 1 drug or device company in 2024. Education make up the largest share, 100% of the total. CSL Behring paid the most, $20.

Dr. Griswold graduated from Boston University School of Medicine in 2012.